ArticleJGH open : an open access journal of gastroenterology and hepatology2021

Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis.

Kento Inada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.